Aurobindo Pharma Limited — Updates, 09-02-2026: Press Release
09-02-2026 | 07:47 pm
09-02-2026 | 07:47 pm
Aurobindo Pharma announced financial results for the quarter and nine months: Revenue rose 8.4% YoY to INR 8,646 Cr, Net Profit up 7.6% to INR 910 Cr. Europe formulations surged 27.4%, US grew 2.2%. 7 USFDA ANDA approvals received. Strong net cash of USD 251mn.
No comments yet. Be the first to comment!
